This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Polymyalgia Rheumatica
Information about Polymyalgia Rheumatica: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Polymyalgia Rheumatica
Most recent studies have shown that Polymyalgia Rheumatica shares some biological mechanisms with arteritis, arthritis, blind-vision, claudication-(finding), degenerative-polyarthritis, edema, giant-cell-arteritis, headache, inflammation, lupus-erythematosus-systemic, malignant-neoplasms, neoplasms, pain, rheumatism, rheumatoid-arthritis, synovitis, temporal-arteritis, vasculitis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Polymyalgia Rheumatica, and have been seen in publications frequently: Acute-phase Response, Aging, Bone Resorption, Cell Activation, Cell Adhesion, Coagulation, Excretion, Granuloma Formation, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Mastication, Pathogenesis, Platelet Aggregation, Reflex, Secretion, Segmentation, Senescence, T Cell Activation
Quite a number of genes have been found to play important roles in Polymyalgia Rheumatica, such as BEST1, C3, CD4, CD8A, CRP, CSRP1, DMD, ESR1, GCA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, IL1RN, IL2, IL6, POMC, TNF, TNFRSF10A, VWF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.